HEK293 EBNA Cells

Unit

3 x 10^6 cells/ml

Cell Type

Immortalized Cells

Tissue Type

Transformed cell lines

Organism

Human

Donor History
Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HEK293-EBNA-Cells/300264

SKU: 300264 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HEK293 EBNA cell line is a derivative of the original HEK293 line, which itself was derived from human embryonic kidney cells grown in tissue culture. This particular subline was engineered to stably express the Epstein-Barr virus nuclear antigen-1 (EBNA-1). The expression of EBNA-1 allows for the episomal replication of plasmids that carry the EBV origin of replication, making HEK293 EBNA cells particularly valuable for the production of recombinant proteins and for gene expression studies involving episomal vectors.

HEK293 EBNA cells retain many of the characteristics of the parent HEK293 cells, including their adherence to cell culture plastic and their robust growth in standard mammalian cell culture media. The addition of EBNA-1 expands their utility in research and biotechnological applications, as it enhances the cells’ ability to propagate plasmids with the EBV origin of plasmid replication. This feature is critical for producing stable, high-yield recombinant proteins, which is essential for both research purposes and industrial-scale production.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.